{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:09:20Z","timestamp":1749874160772,"version":"3.41.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"DOI":"10.7759\/cureus.85959","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:33:21Z","timestamp":1749864801000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparing Dydrogesterone Versus Medroxyprogesterone in Progestin-Primed Ovarian Stimulation (PPOS) for Patients Undergoing In Vitro Fertilization\/Intracytoplasmic Sperm Injection: A Systematic Review"],"prefix":"10.7759","author":[{"given":"R","family":"Muharam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha Nurdya","family":"Nurdya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward  C","family":"Yo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanadi","family":"Sumapraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achmad Kemal","family":"Harzif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mila","family":"Maidarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Budi","family":"Wiweko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andon","family":"Hestiantoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: definition and epidemiology","volume":"62","author":"Vander Borght M","year":"2018","unstructured":"Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018, 62:2-10. 10.1016\/j.clinbiochem.2018.03.012","journal-title":"Clin Biochem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoz044","article-title":"Survey on ART and IUI: legislation, regulation, funding and registries in European countries: the European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"2020","author":"Calhaz-Jorge C","year":"2020","unstructured":"Calhaz-Jorge C, De Geyter CH, Kupka MS, et al.. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: the European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open. 2020, 2020:hoz044. 10.1093\/hropen\/hoz044","journal-title":"Hum Reprod Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00197","article-title":"New twists in ovarian stimulation and their practical implications","volume":"6","author":"Pirtea P","year":"2019","unstructured":"Pirtea P, de Ziegler D, Poulain M, Ayoubi JM. New twists in ovarian stimulation and their practical implications. Front Med (Lausanne). 2019, 6:197. 10.3389\/fmed.2019.00197","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A systematic review of randomized trials for\u00a0the\u00a0treatment of poor ovarian responders: is\u00a0there\u00a0any light at the end of the tunnel?","volume":"96","author":"Polyzos NP","year":"2011","unstructured":"Polyzos NP, Devroey P. A systematic review of randomized trials for\u00a0the\u00a0treatment of poor ovarian responders: is\u00a0there\u00a0any light at the end of the tunnel?. Fertil Steril. 2011, 96:1058-61.e7. 10.1016\/j.fertnstert.2011.09.048","journal-title":"Fertil Steril"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang Y","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, et al.. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015, 104:62-70.e3. 10.1016\/j.fertnstert.2015.03.022","journal-title":"Fertil Steril"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen Q","year":"2019","unstructured":"Chen Q, Chai W, Wang Y, et al.. Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial. Front Endocrinol (Lausanne). 2019, 10:796. 10.3389\/fendo.2019.00796","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang Y","year":"2016","unstructured":"Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y. Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial. Medicine (Baltimore). 2016, 95:e2939. 10.1097\/MD.0000000000002939","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-017-0291-0","article-title":"Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders","volume":"15","author":"Chen Q","year":"2017","unstructured":"Chen Q, Wang Y, Sun L, et al.. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol. 2017, 15:71. 10.1186\/s12958-017-0291-0","journal-title":"Reprod Biol Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2414783","article-title":"Progestin-primed ovarian stimulation outcomes in in-vitro fertilization (IVF) - a systematic review of the literature","volume":"40","author":"Lokshin VN","year":"2024","unstructured":"Lokshin VN, Temirkhanovna Abshekenova A, Di Renzo GC, Feichtinger M, Kenesovna Karibayeva S, Margulanovna Syzdykova D. Progestin-primed ovarian stimulation outcomes in in-vitro fertilization (IVF) - a systematic review of the literature. Gynecol Endocrinol. 2024, 40:2414783. 10.1080\/09513590.2024.2414783","journal-title":"Gynecol Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson WS","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995, 123:A12-3.","journal-title":"ACP J Club"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.708704","article-title":"Comparison of dydrogesterone and medroxyprogesterone in the progestin-primed ovarian stimulation protocol for patients with poor ovarian response","volume":"12","author":"Zhang J","year":"2021","unstructured":"Zhang J, Du M, Li Z, Liu W, Ren B, Zhang Y, Guan Y. Comparison of dydrogesterone and medroxyprogesterone in the progestin-primed ovarian stimulation protocol for patients with poor ovarian response. Front Endocrinol (Lausanne). 2021, 12:708704. 10.3389\/fendo.2021.708704","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study","volume":"13","author":"Huang J","year":"2019","unstructured":"Huang J, Xie Q, Lin J, et al.. Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study. Drug Des Devel Ther. 2019, 13:4461-70. 10.2147\/DDDT.S230129","journal-title":"Drug Des Devel Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu S","year":"2018","unstructured":"Yu S, Long H, Chang HY, et al.. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles. Hum Reprod. 2018, 33:229-37. 10.1093\/humrep\/dex367","journal-title":"Hum Reprod"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366086-comparing-dydrogesterone-versus-medroxyprogesterone-in-progestin-primed-ovarian-stimulation-ppos-for-patients-undergoing-in-vitro-fertilizationintracytoplasmic-sperm-injection-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:33:22Z","timestamp":1749864802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366086-comparing-dydrogesterone-versus-medroxyprogesterone-in-progestin-primed-ovarian-stimulation-ppos-for-patients-undergoing-in-vitro-fertilizationintracytoplasmic-sperm-injection-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.85959","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}